MARKET

NPCE

NPCE

Neuropace Inc
NASDAQ
9.35
-0.20
-2.09%
Closed 16:24 07/15 EDT
OPEN
9.58
PREV CLOSE
9.55
HIGH
9.58
LOW
9.26
VOLUME
191.79K
TURNOVER
0
52 WEEK HIGH
18.98
52 WEEK LOW
5.45
MARKET CAP
306.67M
P/E (TTM)
-11.2596
1D
5D
1M
3M
1Y
5Y
1D
AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates
NASDAQ · 1d ago
Weekly Report: what happened at NPCE last week (0707-0711)?
Weekly Report · 2d ago
Citizens JMP pharmaceuticals analysts hold analyst/industry conference call
TipRanks · 07/07 20:20
Weekly Report: what happened at NPCE last week (0630-0704)?
Weekly Report · 07/07 11:51
Weekly Report: what happened at NPCE last week (0623-0627)?
Weekly Report · 06/30 12:00
NeuroPace: Volatile, Uncertain, But Promising
Seeking Alpha · 06/29 20:00
NeuroPace (NPCE) Receives a Buy from Leerink Partners
TipRanks · 06/26 15:15
Lake Street Keeps Their Buy Rating on NeuroPace (NPCE)
TipRanks · 06/25 12:55
More
About NPCE
NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.

Webull offers Neuropace Inc stock information, including NASDAQ: NPCE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NPCE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NPCE stock methods without spending real money on the virtual paper trading platform.